Evidence map›Paper›PMID 29876136›Full record

ArticleVirus evolution2018

Easy and accurate reconstruction of whole HIV genomes from short-read sequence data with shiver.

Chris Wymant, François Blanquart, Tanya Golubchik, Astrid Gall, Margreet Bakker, Daniela Bezemer, Nicholas J Croucher, Matthew Hall, Mariska Hillebregt, Swee Hoe Ong and 23 more

Abstract read
In one paragraph

Article in Virus evolution, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Chris WymantBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-9847-8226
François BlanquartMedical Research Council Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
Tanya GolubchikBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Astrid GallDepartment of Veterinary Medicine, University of Cambridge, Cambridge, UK.
Margreet BakkerLaboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
Daniela BezemerStichting HIV Monitoring, Amsterdam, The Netherlands.
Nicholas J CroucherMedical Research Council Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
Matthew HallBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Mariska HillebregtStichting HIV Monitoring, Amsterdam, The Netherlands.
Swee Hoe OngVirus Genomics, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-3629-5387
Oliver RatmannMedical Research Council Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
Jan AlbertDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Norbert BannertDivision for HIV and Other Retroviruses, Robert Koch Institute, Berlin, Germany.
Jacques FellaySchool of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Katrien FransenHIV/STI Reference Laboratory, Department of Clinical Science, WHO Collaborating Centre, Institute of Tropical Medicine, Antwerpen, Belgium.
Annabelle GourlayInstitute for Global Health, University College London, London, UK.
M Kate GrabowskiDepartment of Pathology, John Hopkins University, Baltimore, MD, USA.
Barbara Gunsenheimer-BartmeyerDepartment of Infectious Disease Epidemiology, Robert Koch-Institute, Berlin, Germany.
Huldrych F GünthardDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Pia KiveläDepartment of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland.
Roger KouyosDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Oliver LaeyendeckerDivision of Intramural Research, NIAID, NIH, Baltimore, MD, USA.
Kirsi LiitsolaDepartment of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland.
Laurence MeyerINSERM CESP U1018, Université Paris Sud, Université Paris Saclay, APHP, Service de Santé Publique, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
Kholoud PorterInstitute for Global Health, University College London, London, UK.
Matti RistolaDepartment of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland.
Ard van SighemStichting HIV Monitoring, Amsterdam, The Netherlands.
Ben BerkhoutLaboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-1905-8486
Marion CornelissenLaboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
Paul KellamKymab Ltd, Cambridge, UK.
Peter ReissStichting HIV Monitoring, Amsterdam, The Netherlands.
Christophe FraserBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0003-2399-9657
BEEHIVE Collaboration

Funding

International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Revealing women's hidden role as critical components of HIV transmission networks in Rakai, Uganda: an interdisciplinary approachK01AI125086 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRABOWSKI, MARY KATHRYN · 2016 to 2020
$638k
European Research Council 339251Medical Research Council MC_U122886351Medical Research Council MC_UU_12023/15Medical Research Council MR/L01632X/1NIAID NIH HHS K01 AI125086
6 · The paper itself

Abstract

Studying the evolution of viruses and their molecular epidemiology relies on accurate viral sequence data, so that small differences between similar viruses can be meaningfully interpreted. Despite its higher throughput and more detailed minority variant data, next-generation sequencing has yet to be widely adopted for HIV. The difficulty of accurately reconstructing the consensus sequence of a quasispecies from reads (short fragments of DNA) in the presence of large between- and within-host diversity, including frequent indels, may have presented a barrier. In particular, mapping (aligning) reads to a reference sequence leads to biased loss of information; this bias can distort epidemiological and evolutionary conclusions.

Indexed as

bioinformaticsdiversitygenome assemblyHIVmappingnext-generation sequencing

Identifiers

PMID29876136
PMCPMC5961307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.